Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of heterologous prime/boost inactivated COVID-19 vaccine and viral vector vaccine
TCTR20210628005Phase 3Completed
- Sponsor
- National Research Council of Thailand
- Start
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by National Research Council of Thailand. Started Jun 2021; status: completed.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210628005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210628005.